与BRCA1相关的BARD1与多基化因子CstF-50的功能相互作用
1Department of Biological Sciences, Columbia University, New York, NY 10027, USA.
Science (New York, N.Y.)
|September 8, 1999
概括
与BRCA1关联的RING域蛋白 (BARD1) 与一个关键的多基化因子 (CstF-50) 相互作用,抑制RNA处理. 这一发现揭示了DNA修复和基因表达调节之间的新联系.
科学领域:
- 分子生物学分子生物学
- 基因表达规范 基因表达规范
- 处理RNA处理RNA处理
背景情况:
- 使者RNA (mRNA) 处理,特别是多基尼化,对于基因表达至关重要,涉及复杂的蛋白质机械.
- 这种机器在RNA合成过程中与转录装置密切相关.
研究的目的:
- 研究BRCA1关联RING域蛋白 (BARD1) 的功能,这是一种核蛋白,其作用以前未知.
- 探索BARD1与mRNA多基化机制的组件之间的潜在相互作用.
主要方法:
- 在体外相互作用试验测试BARD1和CstF-50之间的蛋白质结合.
- 使用完整细胞进行基于细胞的测定,以确认BARD1-CstF-50相互作用.
- RNA聚合酶II相互作用研究.
主要成果:
- 发现BARD1与CstF-50 (裂变刺激因子) 相互作用,这是一个关键的多基化因子.
- 在实验室中,BARD1和CstF-50之间的相互作用被证明可以抑制多基化.
- 观察到BARD1和CstF-50都与RNA聚合酶II相互作用.
结论:
- 通过BARD1介导的多基酶抑制可能会在转录过程中防止异常RNA处理,可能在DNA修复部位.
- 这些发现揭示了DNA修复途径和RNA处理事件之间的意想不到的整合.
- 这项研究确定了BARD1作为一种连接转录,RNA处理和DNA修复的新型调节器.
相关概念视频
01:57Protein Complexes with Interchangeable Parts
Groups of proteins may form a complex where each protein in this complex has a different role in the overall execution of the complex’s function. Often some of the proteins in the complex can be replaced by a closely related variant to give a complex that contains many of the same components yet is functionally distinct.
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order to...
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order to...
02:36DNA Damage can Stall the Cell Cycle
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
02:36DNA Damage Can Stall the Cell Cycle
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...